pubmed-article:21293012 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C0215848 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C1420229 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:21293012 | lifeskim:mentions | umls-concept:C1332838 | lld:lifeskim |
pubmed-article:21293012 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21293012 | pubmed:dateCreated | 2011-2-21 | lld:pubmed |
pubmed-article:21293012 | pubmed:abstractText | The sodium-calcium exchanger-1 (NCX1) represents a key mediator for maintaining [Na(+)](i) and [Ca(2+)](i) homeostasis. Although changes in NCX1 protein and transcript expression have been detected during stroke, its transcriptional regulation is still unknown. Thus far, however, there is evidence that hypoxia-inducible factor-1 (HIF-1) is a nuclear factor required for transcriptional activation of several genes implicated in stroke. The main objective of this study was to investigate whether NCX1 gene might be a novel target of HIF-1 in the brain. | lld:pubmed |
pubmed-article:21293012 | pubmed:language | eng | lld:pubmed |
pubmed-article:21293012 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21293012 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21293012 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21293012 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21293012 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21293012 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21293012 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21293012 | pubmed:issn | 1524-4628 | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:AnnunziatoLuc... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:ZambranoNicol... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:SirabellaRoss... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:Di... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:BosciaFrances... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:PignataroGius... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:Del... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:ScorzielloAnt... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:MatroneCarmel... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:ValsecchiVale... | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:EspositoElgaE | lld:pubmed |
pubmed-article:21293012 | pubmed:author | pubmed-author:SisalliMaria... | lld:pubmed |
pubmed-article:21293012 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21293012 | pubmed:volume | 42 | lld:pubmed |
pubmed-article:21293012 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21293012 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21293012 | pubmed:pagination | 754-63 | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:meshHeading | pubmed-meshheading:21293012... | lld:pubmed |
pubmed-article:21293012 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21293012 | pubmed:articleTitle | NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. | lld:pubmed |
pubmed-article:21293012 | pubmed:affiliation | Division of Pharmacology, Department of Neuroscience, School of Medicine, "Federico II" University of Naples, Via S. Pansini 5, 80131 Naples, Italy. | lld:pubmed |
pubmed-article:21293012 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21293012 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:21293012 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:29560 | entrezgene:pubmed | pubmed-article:21293012 | lld:entrezgene |
entrez-gene:29715 | entrezgene:pubmed | pubmed-article:21293012 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21293012 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21293012 | lld:entrezgene |